News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,054 Results
Type
Article (19989)
Company Profile (128)
Press Release (312937)
Section
Business (105382)
Career Advice (879)
Deals (18534)
Drug Delivery (97)
Drug Development (50778)
Employer Resources (79)
FDA (7686)
Job Trends (7743)
News (185878)
Policy (17334)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (733)
Accelerated approval (3)
Adcomms (17)
Allergies (40)
Alliances (27835)
ALS (53)
Alzheimer's disease (632)
Antibody-drug conjugate (ADC) (88)
Approvals (7701)
Artificial intelligence (136)
Autoimmune disease (12)
Automation (4)
Bankruptcy (177)
Best Places to Work (5553)
BIOSECURE Act (13)
Biosimilars (94)
Biotechnology (57)
Bladder cancer (30)
Brain cancer (18)
Breast cancer (104)
Cancer (1013)
Cardiovascular disease (109)
Career advice (711)
Career pathing (20)
CAR-T (54)
Cell therapy (149)
Cervical cancer (5)
Clinical research (42623)
Collaboration (446)
Compensation (153)
Complete response letters (23)
COVID-19 (1099)
CRISPR (21)
C-suite (142)
Cystic fibrosis (56)
Data (1072)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (137)
Diagnostics (1808)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (75)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (57)
Earnings (38985)
Editorial (29)
Employer branding (10)
Employer resources (73)
Events (48501)
Executive appointments (420)
FDA (8248)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (301)
Gene editing (45)
Generative AI (17)
Gene therapy (142)
GLP-1 (578)
Government (1833)
Grass and pollen (2)
Guidances (18)
Healthcare (5904)
Huntington's disease (13)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (17)
Infectious disease (1177)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (53)
Interviews (116)
IPO (7366)
IRA (45)
Job creations (2432)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (274)
Leadership (13)
Legal (4114)
Liver cancer (31)
Lung cancer (154)
Lymphoma (83)
Machine learning (2)
Management (30)
Manufacturing (191)
MASH (47)
Medical device (1962)
Medtech (1965)
Mergers & acquisitions (11406)
Metabolic disorders (474)
Multiple sclerosis (48)
NASH (20)
Neurodegenerative disease (46)
Neuropsychiatric disorders (20)
Neuroscience (930)
NextGen: Class of 2025 (2358)
Non-profit (906)
Northern California (1039)
Now hiring (20)
Obesity (296)
Opinion (189)
Ovarian cancer (33)
Pain (65)
Pancreatic cancer (35)
Parkinson's disease (81)
Partnered (11)
Patents (130)
Patient recruitment (45)
Peanut (16)
People (33402)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13344)
Phase II (18031)
Phase III (14489)
Pipeline (681)
Podcasts (69)
Policy (103)
Postmarket research (1618)
Preclinical (4650)
Press Release (29)
Prostate cancer (58)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (231)
Real estate (3171)
Recruiting (29)
Regulatory (12502)
Reports (22)
Research institute (818)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (24)
Schizophrenia (58)
Series A (56)
Series B (31)
Service/supplier (6)
Sickle cell disease (35)
Southern California (997)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2008)
State (2)
Stomach cancer (9)
Supply chain (49)
Tariffs (14)
The Weekly (49)
United States (9763)
Vaccines (265)
Venture capitalists (27)
Webinars (11)
Weight loss (233)
Women's health (14)
Worklife (7)
Date
Today (59)
Last 7 days (399)
Last 30 days (1423)
Last 365 days (17020)
2025 (4312)
2024 (17669)
2023 (19637)
2022 (25865)
2021 (26639)
2020 (24870)
2019 (20057)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (409)
Alabama (22)
Alaska (1)
Arizona (64)
Arkansas (8)
Asia (24856)
Australia (3212)
California (2430)
Canada (1070)
China (313)
Colorado (95)
Connecticut (96)
Delaware (68)
Europe (51309)
Florida (419)
Georgia (53)
Idaho (16)
Illinois (238)
India (19)
Indiana (168)
Iowa (3)
Japan (111)
Kansas (60)
Kentucky (17)
Louisiana (2)
Maine (4)
Maryland (354)
Massachusetts (2052)
Michigan (46)
Minnesota (133)
Mississippi (1)
Missouri (27)
Montana (10)
Nebraska (11)
Nevada (15)
New Hampshire (8)
New Jersey (989)
New Mexico (21)
New York (713)
North Carolina (487)
North Dakota (2)
Northern California (1039)
Ohio (80)
Oklahoma (5)
Oregon (21)
Pennsylvania (572)
Puerto Rico (10)
Rhode Island (14)
South America (606)
South Carolina (3)
Southern California (997)
Tennessee (38)
Texas (323)
Utah (53)
Virginia (79)
Washington D.C. (41)
Washington State (209)
Wisconsin (19)
333,054 Results for "promore pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Report from the Extraordinary General Meeting of Promore Pharma AB Held on 29 December 2023
Promore Pharma Promore Pharma AB, under change of name to PMD Device Solutions AB, held an extraordinary general meeting on Friday, 29 December 2023.
December 29, 2023
·
3 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Policy
Promore Pharma initiates voluntary liquidation
Promore Pharma AB announced that the company has entered into voluntary liquidation and that the Swedish Companies Registration Office has appointed attorney Lars-Henrik Andersson as liquidator.
October 12, 2023
·
3 min read
Notice of Extraordinary General Meeting in Promore Pharma AB (Publ)
The shareholders of Promore Pharma AB, reg. no. 556639-6809, are hereby invited to an extraordinary general meeting on 29 December 2023 at 10:00 am CET at Eversheds Sutherland’s premises at Sveavägen 20, 111 57 Stockholm.
November 29, 2023
·
4 min read
Promore Pharma Engages Erik Penser Bank as Liquidity Provider
Promore Pharma AB announced that the company has entered into an agreement with Erik Penser Bank to act as liquidity provider for the Promore Pharma share starting 21 August 2023.
August 16, 2023
·
1 min read
Deals
Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB
Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.
November 29, 2023
·
12 min read
Report from the Extraordinary General Meeting of Promore Pharma AB held on 5 October 2023
Promore Pharma AB, reg. no. 556639-6809, held an extraordinary general meeting on Thursday, 5 October 2023.
October 5, 2023
·
2 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Promore Pharma’s Annual Report 2022
The 2022 Annual report of Promore Pharma AB is now available on the Company’s website.
May 9, 2023
·
1 min read
Notice of Extraordinary General Meeting Promore Pharma AB (Publ)
Promore Pharma AB will hold an Extraordinary General Meeting on Thursday, 5 October 2023 at 10.00 am, in Advokaterna Liman & Partners AB:s premises at Grev Turegatan 38, 114 38 Stockholm.
September 18, 2023
·
6 min read
1 of 33,306
Next
